• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    The Role of Heat Shock Proteins, Amyloid Precursor Protein and B-cell CLL/lymphoma 3 and their Co-chaperones in Colorectal Cancer 
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • The Role of Heat Shock Proteins, Amyloid Precursor Protein and B-cell CLL/lymphoma 3 and their Co-chaperones in Colorectal Cancer
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • The Role of Heat Shock Proteins, Amyloid Precursor Protein and B-cell CLL/lymphoma 3 and their Co-chaperones in Colorectal Cancer
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    The Role of Heat Shock Proteins, Amyloid Precursor Protein and B-cell CLL/lymphoma 3 and their Co-chaperones in Colorectal Cancer

    View/Open
    Anil Ghosh PhD.pdf (4.619Mb)
    Publisher
    Queen Mary University of London
    Metadata
    Show full item record
    Abstract
    The elevated expression of Heat shock proteins (HSPs) has been implicated in CRC prognosis and tumour cells may require the expression of HSPs and BCL2-associated athanogene (BAG1), the HSP co-chaperone, to survive. BAG1 is a regulator of amyloid precursor protein (APP); both are important in cellular proliferation and cancer. B-cell CLL/lymphoma 3 (BCL3) is an agonist in the tumour-associated NF-κB pathway. This study aims to establish the mutational status of TP53, KRAS and PIK3CA, and the activation status of AKT, in primary CRCs and then investigate the role of HSPs, BAG1, APP, and BCL3. Oncogene induced senescence (OIS) is a potential roadblock to CRC. Recent cell culture studies suggest that OIS mediated by PI3K/AKT activation can be circumvented by high expression of HSPs in the absence of TP53 mutation. While PI3K/AKT activation and KRAS mutations are independent inducers of OIS, PI3K/AKT activation can suppress KRAS-induced OIS when both are present in cultured cells. KRAS mutations, PI3K/AKT activation and TP53 mutations are all common features of CRCs. For HSP to inhibit OIS in CRC may be dependent on the tumour’s mutation spectrum. CRCs with oncogenic activation of the AKT pathway were associated with increased HSP27 expression, which may represent an important mechanism in suppressing p53 dependent senescence. No association was found between HSP27 or HSP72 expression with TP53 mutation status, but HSP27 expression was strongly associated with the co-presence of wildtype KRAS and activated PI3K/AKT, indicating a possible 4 role of HSP27 in overcoming PI3K/AKT induced OIS in tumours. There was no correlation between BAG1 and APP co-expression in CRCs. BCL3 expression was heterogeneous, and elevated at the invasive edge. The expression of HSPs, APP, BCL3 was not correlated with any CRC clinicopathological features. Our studies suggest a role for using archival tissues in validating hypotheses generated from cell culture based investigations
    Authors
    Ghosh, Anil Kumar
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/8392
    Collections
    • Theses [3366]
    Copyright statements
    The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.